Tag: $GSK

GSK raises 2023 outlook boosted by vaccine, HIV drug sales

LONDON July 26 – GSK raised its full-year profit and sales guidance on Wednesday after its second-quarter earnings beat expectations, helped by strong sales of its shingles vaccine Shingrix and HIV medicines.


GSK Stock Climbs on Zantac Settlement. Drug Maker Avoids a California Trial.

U.S.-listed shares of GSK were rising in premarket trading Friday after the pharmaceutical company said it reached a first legal settlement over claims that heartburn medication Zantac can cause cancer.